Table 1 Patient demographics and outcome characteristics of patients among groups
From: A novel “three-port” trocar placement technique for laparoscopic radical prostatectomy
Variables | Group A | Group B | Group C | Group D | p value | p value after comparison | ||
|---|---|---|---|---|---|---|---|---|
A vs B | A vs C | A vs D | ||||||
No. patients | 144 | 88 | 57 | 11 | – | – | – | – |
Age (years) | 66.0 ± 7.1 | 67.7 ± 6.8 | 66.5 ± 6.3 | 68.6 ± 8.5 | 0.244 | – | – | – |
BMI (kg/m2) | 24.2 ± 2.6 | 24.8 ± 2.9 | 24.6 ± 2.7 | 23.6 ± 2.9 | 0.253 | – | – | – |
Smoking history (%) | 16 (11.1%) | 15 (17.0%) | 6 (10.7%) | 2 (18.2%) | 0.470 | – | – | – |
ADT history (%) | 16 (11.1%) | 5 (5.7%) | 1 (1.8%) | 1 (9.1%) | 0.100 | – | – | – |
PSA level (ng/ml) | 13.4 ± 12.1 | 15.2 ± 12.6 | 14.1 ± 27.3 | 15.2 ± 17.7 | 0.867 | – | – | – |
Prostate volume (ml) | 35.2 ± 16.0 | 42.6 ± 26.7 | 46.7 ± 25.2 | 36.6 ± 11.5 | 0.003 | 0.118 | 0.013 | 0.999 |
Preoperative Gleason scores by puncture (%) | ||||||||
< 7 | 37 (25.7%) | 30 (34.1%) | 20 (35.1%) | 5 (45.4%) | 0.113 | – | – | – |
= 7 | 88 (61.1%) | 38 (43.2%) | 28 (49.1%) | 4 (36.4%) | ||||
> 7 | 19 (13.2%) | 20 (22.7%) | 9 (15.8%) | 2 (18.2%) | ||||
EBL (ml) | 94.2 ± 73.4 | 216.7 ± 173.2 | 1247.9 ± 1137.2 | 150.0 ± 130.4 | < 0.001 | < 0.001 | < 0.001 | 0.661 |
OT (min) | 113.8 ± 21.1 | 130.6 ± 30.3 | 240.1 ± 52.1 | 214.4 ± 38.8 | < 0.001 | 0.002 | < 0.001 | < 0.001 |
Drainage days (days) | 4.0 ± 2.6 | 3.7 ± 2.9 | 6.4 ± 5.7 | 4.5 ± 1.6 | < 0.001 | 0.973 | 0.018 | 0.913 |
Hospitalization days (days) | 5.1 ± 2.9 | 5.2 ± 3.4 | 8.8 ± 5.8 | 6.3 ± 2.5 | < 0.001 | 1.000 | < 0.001 | 0.647 |
Transfusion (ml) | 0 | 4.5 ± 42.6 | 652.6 ± 789.8 | 0 | < 0.001 | 0.897 | < 0.001 | – |
Complications | ||||||||
0 | 130 (96.3%) | 81 (92.0%) | 52 (91.2%) | 10 (90.9%) | 0.104 | – | – | – |
I | 4 (3.0%) | 5 (5.7%) | 3 (5.3%) | 0 | ||||
II | 1 (0.7%) | 0 | 2 (3.5%) | 1 (9.1%) | ||||
III | 0 | 2 (2.3%) | 0 | 0 | ||||
Postoperatively pathological stages (%) | ||||||||
T2 | 87 (60.4%) | 41 (46.6%) | 34 (59.6%) | 5 (45.5%) | 0.161 | – | – | – |
T3 | 57 (39.6%) | 47 (53.4%) | 23 (40.4%) | 6 (54.5%) | ||||
PSM (%) | 40 (27.8%) | 27 (30.7%) | 19 (33.3%) | 4 (36.4%) | 0.792 | – | – | – |
Postoperative Gleason scores by operation (%) | ||||||||
< 7 | 10 (6.9%) | 9 (10.2%) | 8 (14.0%) | 1 (9.1%) | 0.242 | – | – | – |
= 7 | 112 (77.8%) | 56 (63.6%) | 39 (68.4%) | 8 (72.7%) | ||||
> 7 | 22 (15.3%) | 23 (26.1%) | 10 (17.6%) | 2 (18.2%) | ||||